Molecules / Ribavirin

Ribavirin API manufacturers

CAS 36791-04-5 ATC J05AB04 · Nucleoside antivirals Updated 9 July 2026
6
manufacturers with an active filing 6 of them hold a US DMF or a CEP
9
shortage records on file across 4 countries
178
finished-dose makers across 37 regulators
Showing 6 of 6 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

Curia Spain S.A.U

Spain
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for ribavirin, filing since 2021. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2023 · VAI
GMP recognised in
2 markets
How this listing is sourced EDQM certificate database
View profile
02

Apitoria Pharma

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF and one valid CEP for ribavirin, filing since 2005. Its 2025 FDA inspection closed as VAI.

US DMF
1 active
CEP
1 valid
Last FDA inspection
2025 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Yuhan Chemical

South Korea
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for ribavirin, filing since 2001. Its 2025 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Zhejiang Cheng Yi Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for ribavirin, filing since 2012. Its 2025 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
05

Siegfried Evionnaz

Switzerland
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for ribavirin, filing since 1996. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
06

Curia Italy

Italy
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for ribavirin, filing since 2001.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile

3 more manufacturers hold filings for ribavirin

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Zhejiang Cheng Yi PharmaceuticalSiegfried EvionnazCuria Italy
Open the full list with a free account

Finished-dose makers (30)

Gilead Sciences United States Navinta United States Msd International Gmbh (Puerto Rico Branch) United States Teva Israel Viatris United States Merck Sharp & Dohme Farmaceutica Ltda Brazil Hoffmann-La Roche Switzerland Lupin India Medichem Spain Sandoz Switzerland Valeant Canada Limitée Canada Zydus Lifesciences India Getz Pharma Pakistan Patheon Canada PharmEvo Pakistan Aurobindo Pharma India October Pharma Egypt Pharmaand Austria Mylan S.A.S France Agimexpharm Pharmaceutical Vietnam

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Map ribavirin for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Also on this molecule

Shortages 9 Recalls 4 Finished dose 30 Contract mfrs 0